Drug class
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
18 drugs the FDA files under Glucose-dependent Insulinotropic Polypeptide Receptor Agonist, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- 0.5 ML tirzepatide 10 MG/ML Auto-Injector [Mounjaro]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 10 MG/ML Auto-Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 15 MG/ML Auto-Injector [Mounjaro]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 15 MG/ML Auto-Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 20 MG/ML Auto-Injector [Mounjaro]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 20 MG/ML Auto-Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 25 MG/ML Auto-Injector [Mounjaro]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 25 MG/ML Auto-Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 30 MG/ML Auto-Injector [Mounjaro]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 30 MG/ML Auto-Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 5 MG/ML Auto-Injector [Mounjaro]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 0.5 ML tirzepatide 5 MG/ML Auto-Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 2.4 ML tirzepatide 12.5 MG/ML Pen Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 2.4 ML tirzepatide 16.7 MG/ML Pen Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 2.4 ML tirzepatide 20.8 MG/ML Pen Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 2.4 ML tirzepatide 25 MG/ML Pen Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 2.4 ML tirzepatide 4.17 MG/ML Pen Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
- 2.4 ML tirzepatide 8.33 MG/ML Pen Injector [Zepbound]Glucose-dependent Insulinotropic Polypeptide Receptor Agonist